Rare Genomics Institute partners with Dante Labs to help children and adults who suffer from rare diseases

/

Los Angeles C.A., February 28, 2019 – Rare Genomics Institute (RG) today announced a partnership with Dante Labs, an Italy and US-based diagnostic laboratory. RG is an international non-profit that gives rare disease patients access to state-of-the-art genomics sequencing technology, connections to scientists and researchers and philanthropic opportunities. Dante Labs is a genetic testing company specialized on whole genome sequencing and rare diseases. Through this partnership, Dante Labs has agreed to provide pro-bono Whole Genome Sequencing to select patients from Rare Genomics. Their test called, Whole Genome Sequencing (Full DNA Analysis), analyzes 100% of the DNA and provides personalized reports based on the patient’s medical history and symptoms.

Read More

Genomenon Partners with Rare Genomics Institute, Begins with Philanthropic Donation

/

ANN ARBOR, MICHIGAN – October 16, 2018 - Genomenon announced today that they will donate Mastermind Genomic Search Engine licenses to the entire team of clinical scientists at Rare Genomics Institute to accelerate their work for patients with rare diseases.

Rare Genomics Institute (RG) is a nonprofit (EIN: 45-3624709) organization that has been at the forefront of providing direct support to undiagnosed rare disease patients and their families since 2011. RG helps patients find a diagnosis, treatment, and cure by connecting them to expert scientists and biomedical researchers who have access to the most advanced technologies to diagnose and accelerate research.

Read More

Rare Genomics Institute Announces the winners of the 2018 BeHeard (Helping Empower and Accelerate Research Discoveries) Rare Disease Science Challenge

/

The Rare Genomics Institute (RG) is delighted to announce the winners of the 2018 BeHEARD (Helping Empower and Accelerate Research Discoveries) Rare Disease Science Challenge, a global competition that offers rare disease researchers, who traditionally have difficulty attracting funding, grants of the latest life science innovations and technologies. This unique crowdsourced biotechnology competition allows companies to contribute their technology to make a difference for the rare disease community.

Read More

Rare Genomic Institute Announces Rare Genomics Task Force (RGTF)

/

The Rare Genomics Institute (RG) has announced a new division – Rare Genomics Task Force (RGTF). It will be tasked with providing scientific information and support for patients with rare diseases. These efforts include but are not limited to conducting research reviews, writing reports for patients, identifying renowned experts who can help with projects, and connecting experts with rare disease patients. RGTF recently started a free and publicly accessible platform that is currently running through email communication.

Read More

Rare Genomic Institute Announces BeHEARD – Annual Rare Disease Science Technology Grants Challenge -- The competition is open globally to foundations, researchers, and doctors –

/

The Rare Genomics Institute (RG) announces the BeHEARD (Helping Empower and Accelerate Research Discoveries) Initiative, an annual rare disease science challenge providing technology grants for rare disease research. The RG-hosted contest is aimed at accelerating rare disease research and offering new options for millions of patients suffering from ailments that lack effective treatments.

Read More

New Research Study Establishes 30 Day Crowdfunding Bootcamp for Rare Diseases

/

RG Press Release: New Research Study Establishes 30 Day Crowdfunding Bootcamp for Rare Diseases.

Rare Genomics Institute (RG) today announced a 30-day Crowdfunding Bootcamp to help rare disease patients raise funds for high-end exome sequencing to pinpoint the cause of their disease and map possible treatments. 

Read More